MW Creators

World News

Vasomotor symptoms (Hot flashes/Night sweats) Market to Witness Upsurge in Growth by 2030, Estimates DelveInsight | Key Companies – Mithra Pharma, Astellas Pharma, Nerre Therapeutics, Fervent Pharma, KaNDy Therapeutics, Sojournix, Mitsubishi Tanabe Pharma, and Others

DelveInsight’s “Vasomotor symptoms (Hot flashes/Night sweats) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Vasomotor symptoms (Hot flashes/Night sweats) market trends in the seven major markets (7MM) (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The market report covers emerging drugs, current treatment practices, market share of the individual therapies, market drivers, barriers, unmet medical needs, current and forecasted market size from 2017 to 2030 segmented by seven major markets. 

Vasomotor symptoms (Hot flashes/Night sweats) Disease Overview

Vasomotor Symptoms (VMS) is one of the major symptoms of menopause that principally include hot flashes (HF) and night sweats (NS) during menopause and occur in the majority of women across the globe. A woman with VMS experiences abundant heat accompanied by sweating and flushing, especially around the head, neck, chest, and upper back region. VMS results from temperature dysfunction that occurs due to changes in gonadal hormones.

Night sweats are Hot Flashes that occur with heavy perspiration during sleep and cause sleep disruption. Women experiencing night sweats have greater motor restlessness in bed, less efficient sleep, and a reduced feeling of restlessness in the morning compared to women without these symptoms.

Vasomotor symptoms (Hot flashes/Night sweats) Market Key Facts

  • The total prevalent population of Vasomotor Symptoms associated with post-menopause in 7MM countries was 41,096,968 in 2017. The prevalent population of Hot Flashes Associated with menopause in 7MM countries is expected to increase.
  • In 2017, prevalent cases of mild, moderate, and severe Hot Flashes in the US varied as 11,762,902, 4,485,612, and 2,678,118 respectively.
  • Among the 7MM, the US accounts for 61% USD of the overall market size of Hot Flashes Associated with Post-Menopause in 2017.
  • Among the EU-5 countries, the UK accounts for the highest market size for Hot Flashes associated with PostMenopause followed by Germany, France, and Italy.
  • The prevalent population of Hot Flashes in Japan was observed at 2,829,757, 1,079,087, and 644,265 cases that account for mild, moderate, and severe symptoms respectively in 2017.
  • As per the estimates, the United States has the highest prevalent population of Hot Flashes associated with Post Menopause with 18,926,632 cases in 2017.

 

Key Benefits of Vasomotor symptoms (Hot flashes/Night sweats) Market Report

  • The market report provides an in-depth analysis of Vasomotor symptoms (Hot flashes/Night sweats) Market size, share, and epidemiology in 7MM.
  • The report will help in developing business strategies by understanding the trends & developments, key players operating in the market, and future competition that will drive and shape the market outlook in the upcoming years.
  • The report covers the factors stimulating the Vasomotor symptoms (Hot flashes/Night sweats) market growth, current treatment practices, emerging drugs, market share of the individual therapies.
  • The report provides a detailed assessment of the patient population, unmet needs, comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

 

Vasomotor symptoms (Hot flashes/Night sweats) Market

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Vasomotor symptoms (Hot flashes/Night sweats) market size and share by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology. 

The report gives a thorough detail of market trends, growth opportunities of each marketed and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Visit to get more detailed insights @ https://www.delveinsight.com/sample-request/vasomotor-symptoms-market

The market size of Vasomotor symptoms (Hot flashes/Night sweats) is expected to increase during the forecast period owing to the increase in the prevalent cases in the 7MM and the launch of targeted therapies.

Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology

The epidemiology section covers insights about historical and current Vasomotor symptoms (Hot flashes/Night sweats) patient pool and forecasted trends for every seven major markets from 2017 to 2030. It helps to recognize the causes of current and forecasted Vasomotor symptoms (Hot flashes/Night sweats) epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Discover more about the epidemiological segmentation @ https://www.delveinsight.com/sample-request/vasomotor-symptoms-market

Among the European 5 countries, Germany had the highest prevalent population of Vasomotor Symptoms, followed by France. On the other hand, Spain had the lowest prevalent population of Vasomotor Symptoms.

Vasomotor symptoms (Hot flashes/Night sweats) Drugs Uptake and Key Market Players

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Vasomotor symptoms (Hot flashes/Night sweats) market or expected to get launched in the market during the study period. The analysis covers the drug uptake; patient uptake by therapies; and sales of each drug.   

 Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Vasomotor symptoms (Hot flashes/Night sweats) Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent development such as collaborations, acquisitions, and mergers, licensing patent details, and other information.

Vasomotor symptoms (Hot flashes/Night sweats) Therapeutics Analysis

Several companies are developing therapies for Vasomotor symptoms (Hot flashes/Night sweats) which are expected to launch in the coming years.

Some of the key companies in the Vasomotor symptoms (Hot flashes/Night sweats) market include:

  • Mithra Pharmaceuticals
  • Astellas Pharma
  • Nerre Therapeutics
  • Fervent Pharmaceuticals
  • KaNDy Therapeutics
  • Sojournix
  • Mitsubishi Tanabe Pharma

And many others.

Vasomotor Symptoms (Hot Flashes/Night Sweats) Therapies covered in the report includes:

  • Donesta
  • Fezolinetant
  • NT-814
  • FP-101 

And many others.

For further information about the emerging therapies and key companies @ https://www.delveinsight.com/sample-request/vasomotor-symptoms-market

 

Table of Content

  1. Key Insights
  2. Executive Summary 
  3. Vasomotor symptoms (Hot flashes/Night sweats) Competitive Intelligence Analysis
  4. Vasomotor symptoms (Hot flashes/Night sweats) Market Overview at a Glance
  5. Vasomotor symptoms (Hot flashes/Night sweats) Disease Background and Overview
  6. Vasomotor symptoms (Hot flashes/Night sweats) Patient Journey
  7. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology and Patient Population
  8. Vasomotor symptoms (Hot flashes/Night sweats) Treatment Algorithm, Current Treatment, and Medical Practices
  9. Vasomotor symptoms (Hot flashes/Night sweats) Unmet Needs
  10. Key Endpoints of Vasomotor symptoms (Hot flashes/Night sweats) Treatment
  11. Vasomotor symptoms (Hot flashes/Night sweats) Marketed Products
  12. Vasomotor symptoms (Hot flashes/Night sweats) Emerging Therapies
  13. Vasomotor symptoms (Hot flashes/Night sweats) Seven Major Market Analysis
  14. Attribute Analysis
  15. Vasomotor symptoms (Hot flashes/Night sweats) Market Outlook (7 major markets)
  16. Vasomotor symptoms (Hot flashes/Night sweats) Access and Reimbursement Overview
  17. KOL Views on the Vasomotor symptoms (Hot flashes/Night sweats) Market.
  18. Vasomotor symptoms (Hot flashes/Night sweats) Market Drivers
  19. Vasomotor symptoms (Hot flashes/Night sweats) Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get a Free Sample Copy of the Report @ https://www.delveinsight.com/sample-request/vasomotor-symptoms-market

Latest Reports By DelveInsight:

Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Forecast

DelveInsight’s ‘Vasomotor symptoms (Hot flashes/Night sweats)– Epidemiology Forecast 2030’ report delivers an in-depth understanding of the Vasomotor symptoms including Hot flashes or night sweats, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Malignant Pleural Mesothelioma (MPM) Market

DelveInsight’s Malignant Pleural Mesothelioma (MPM) Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed overview of the disease and the historical and forecasted Malignant Pleural Mesothelioma (MPM) market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

Dysautonomia (Autonomic Dysfunction) Market

DelveInsight’s Dysautonomia (Autonomic Dysfunction) Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and the historical and forecasted Dysautonomia market trends and growth in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

Latest Healthcare Blogs By DelveInsight:

 

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Info:
Shruti Thakur
DelveInsight Business Research LLP
Phone No: +91-9650213330
Email: [email protected]
Website: https://www.delveinsight.com/
Connect With Us: LinkedIn | Facebook | Twitter
For Latest Update: Healthcare Blog
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/vasomotor-symptoms-market

 

Leave a Reply

Your email address will not be published. Required fields are marked *